Timothy R. Franson

524 total citations
23 papers, 401 citations indexed

About

Timothy R. Franson is a scholar working on Epidemiology, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, Timothy R. Franson has authored 23 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 4 papers in Pediatrics, Perinatology and Child Health and 3 papers in Pharmacology. Recurrent topics in Timothy R. Franson's work include Urinary Tract Infections Management (4 papers), Geriatric Care and Nursing Homes (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Timothy R. Franson is often cited by papers focused on Urinary Tract Infections Management (4 papers), Geriatric Care and Nursing Homes (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Timothy R. Franson collaborates with scholars based in United States, Australia and France. Timothy R. Franson's co-authors include Raymond G. Hoffmann, Edmund H. Duthie, Harold D. Rose, Peter G. Sohnle, James E. Cooper, Francis L. A. Buckmire, Edward J. Quebbeman, Robert K. Ausman, James R. Sanger and Julianne K. Whipple and has published in prestigious journals such as Critical Care Medicine, Journal of Clinical Epidemiology and Journal of the American Geriatrics Society.

In The Last Decade

Timothy R. Franson

23 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Timothy R. Franson United States 13 137 84 75 66 62 23 401
Per Engervall Sweden 15 161 1.2× 46 0.5× 32 0.4× 54 0.8× 54 0.9× 31 581
C. Venet France 13 255 1.9× 43 0.5× 162 2.2× 76 1.2× 51 0.8× 19 722
Roser Terradas Spain 10 182 1.3× 77 0.9× 78 1.0× 50 0.8× 22 0.4× 23 435
Galit Rabino Israel 10 143 1.0× 87 1.0× 68 0.9× 236 3.6× 35 0.6× 13 501
Daniel Shirley United States 12 141 1.0× 153 1.8× 38 0.5× 49 0.7× 25 0.4× 34 564
P. Jarno France 8 79 0.6× 38 0.5× 53 0.7× 156 2.4× 23 0.4× 19 354
Carmi Bartal Israel 12 93 0.7× 46 0.5× 107 1.4× 103 1.6× 46 0.7× 25 505
James K. Todd United States 9 299 2.2× 72 0.9× 31 0.4× 69 1.0× 32 0.5× 10 553
John W. Hoyt United States 11 165 1.2× 80 1.0× 224 3.0× 115 1.7× 14 0.2× 40 584
Wu Gong United States 11 119 0.9× 108 1.3× 24 0.3× 108 1.6× 90 1.5× 35 442

Countries citing papers authored by Timothy R. Franson

Since Specialization
Citations

This map shows the geographic impact of Timothy R. Franson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy R. Franson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy R. Franson more than expected).

Fields of papers citing papers by Timothy R. Franson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy R. Franson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy R. Franson. The network helps show where Timothy R. Franson may publish in the future.

Co-authorship network of co-authors of Timothy R. Franson

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy R. Franson. A scholar is included among the top collaborators of Timothy R. Franson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy R. Franson. Timothy R. Franson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Buie, Joy, Eric F. Morand, Ronald van Vollenhoven, et al.. (2023). Meeting report: the ALPHA project: a stakeholder meeting on lupus clinical trial outcome measures and the patient perspective. Lupus Science & Medicine. 10(1). e000901–e000901. 1 indexed citations
2.
Franson, Timothy R., Kathi Kinnett, & Timothy P. Cripe. (2018). Unique Burdens of Pediatric Clinical Trials in Duchenne Muscular Dystrophy, April 20–21, 2017, Bethesda, Maryland, USA. Therapeutic Innovation & Regulatory Science. 53(1). 154–163. 9 indexed citations
3.
Furlong, Pat, John F. P. Bridges, Lawrence Charnas, et al.. (2015). How a patient advocacy group developed the first proposed draft guidance document for industry for submission to the U.S. Food and Drug Administration. Orphanet Journal of Rare Diseases. 10(1). 82–82. 35 indexed citations
4.
McAllister, Ryan, Timothy R. Franson, & Carl Kraus. (2013). The Practicing Clinician and Regulatory Safety Concerns. Current Drug Safety. 8(1). 17–24. 2 indexed citations
5.
Whipple, Julianne K., Robert K. Ausman, Timothy R. Franson, & Edward J. Quebbeman. (1991). Effect of individualized pharmacokinetic dosing on patient outcome. Critical Care Medicine. 19(12). 1480–1485. 34 indexed citations
6.
Brater, D. Craig, Beth Benedict, Timothy R. Franson, et al.. (1991). Panel I. Drug utilization review: Criteria*. Clinical Pharmacology & Therapeutics. 50(5 Pt 2). 626–628. 1 indexed citations
7.
Sanger, James R., et al.. (1989). Adherence of Microorganisms to Breast Prostheses: An In Vitro Study. Annals of Plastic Surgery. 22(4). 337–342. 16 indexed citations
8.
Franson, Timothy R., et al.. (1988). Comparison of methods for calculation and depiction of incidence infection rates in long-term care facilities. Journal of Clinical Epidemiology. 41(8). 757–761. 9 indexed citations
9.
Franson, Timothy R., et al.. (1988). Documentation and Evaluation of Fevers in Hospital-Based and Community-Based Nursing Homes. Infection Control and Hospital Epidemiology. 9(10). 447–450. 17 indexed citations
10.
Franson, Timothy R., et al.. (1988). Prospective comparison of traditional and pharmacokinetic aminoglycoside dosing methods. Critical Care Medicine. 16(9). 840–843. 18 indexed citations
11.
Franson, Timothy R., et al.. (1988). Documentation and Evaluation of Fevers in Hospital-Based and Community-Based Nursing Homes. Infection Control and Hospital Epidemiology. 9(10). 447–450. 9 indexed citations
12.
Duthie, Edmund H., et al.. (1988). Survey of nursing personnel attitudes toward infections and their control in the elderly. American Journal of Infection Control. 16(4). 159–166. 5 indexed citations
13.
Franson, Timothy R., et al.. (1987). Institution-specific versus published in vitro antimicrobial susceptibility data in making formulary decisions. American Journal of Health-System Pharmacy. 44(1). 95–101. 4 indexed citations
14.
Dunne, W. Michael & Timothy R. Franson. (1986). Coagulase-negative staphylococci: The rodney dangerfield of pathogens. Clinical Microbiology Newsletter. 8(6). 37–42. 4 indexed citations
15.
Franson, Timothy R., et al.. (1986). Prevalence Survey of Infections and Their Predisposing Factors at a Hospital‐Based Nursing Home Care Unit. Journal of the American Geriatrics Society. 34(2). 95–100. 64 indexed citations
16.
Franson, Timothy R., et al.. (1985). Implementing a Successful Hepatitis B Vaccination Program. Infection Control. 6(8). 306–309. 14 indexed citations
17.
Franson, Timothy R., et al.. (1984). Scanning Electron Microscopy ofBacteria Adherent toIntravascular Catheters. 3 indexed citations
18.
Franson, Timothy R., et al.. (1984). Late-onset, warfarin-caused necrosis occurring in a patient with infectious mononucleosis.. PubMed. 120(7). 927–31. 26 indexed citations
19.
Franson, Timothy R.. (1984). Late-Onset, Warfarin-Caused Necrosis Occurring in a Patient With Infectious Mononucleosis. Archives of Dermatology. 120(7). 927–927. 12 indexed citations
20.
Rose, Harold D., et al.. (1983). In vitro quantitative adherence of bacteria to intravascular catheters. Journal of Surgical Research. 34(3). 213–218. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Per Engervall Breakdown of academic impact, for papers by C. Venet Breakdown of academic impact, for papers by Roser Terradas Breakdown of academic impact, for papers by Galit Rabino Breakdown of academic impact, for papers by Daniel Shirley Breakdown of academic impact, for papers by P. Jarno Breakdown of academic impact, for papers by Carmi Bartal Breakdown of academic impact, for papers by James K. Todd Breakdown of academic impact, for papers by John W. Hoyt Breakdown of academic impact, for papers by Wu Gong
Rankless by CCL
2026